CINECA IRIS Institutional Research Information System

LANOTTE, Michele Maria Rosario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.467
EU - Europa 7.707
AS - Asia 2.866
AF - Africa 238
SA - Sud America 157
OC - Oceania 97
Continente sconosciuto - Info sul continente non disponibili 35
Totale 20.567
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.180
IT - Italia 2.164
CN - Cina 1.453
DE - Germania 852
SE - Svezia 749
IE - Irlanda 726
FR - Francia 661
UA - Ucraina 547
FI - Finlandia 426
SG - Singapore 386
GB - Regno Unito 371
KR - Corea 319
CA - Canada 254
PL - Polonia 222
JP - Giappone 170
AT - Austria 154
VN - Vietnam 152
DK - Danimarca 151
NL - Olanda 147
ES - Italia 118
IN - India 115
BE - Belgio 103
BR - Brasile 101
AU - Australia 86
CH - Svizzera 59
TW - Taiwan 55
TR - Turchia 54
RU - Federazione Russa 47
PT - Portogallo 43
HK - Hong Kong 35
UZ - Uzbekistan 34
CD - Congo 33
EU - Europa 33
GR - Grecia 31
MG - Madagascar 29
RO - Romania 29
MX - Messico 27
AR - Argentina 23
BG - Bulgaria 20
DZ - Algeria 19
SN - Senegal 19
CZ - Repubblica Ceca 18
MA - Marocco 18
ZA - Sudafrica 18
TN - Tunisia 16
CL - Cile 15
IR - Iran 15
IL - Israele 14
TG - Togo 13
IQ - Iraq 12
TH - Thailandia 12
BY - Bielorussia 11
NO - Norvegia 11
NZ - Nuova Zelanda 11
EG - Egitto 9
BF - Burkina Faso 8
CI - Costa d'Avorio 8
NG - Nigeria 8
SI - Slovenia 8
CG - Congo 7
CM - Camerun 7
HR - Croazia 7
HU - Ungheria 7
ID - Indonesia 7
PK - Pakistan 7
GN - Guinea 6
IS - Islanda 6
PE - Perù 6
CO - Colombia 5
MY - Malesia 5
RS - Serbia 5
AE - Emirati Arabi Uniti 4
BI - Burundi 4
KZ - Kazakistan 4
PH - Filippine 4
SA - Arabia Saudita 4
SK - Slovacchia (Repubblica Slovacca) 4
TD - Ciad 4
BJ - Benin 3
EC - Ecuador 3
GF - Guiana Francese 3
EE - Estonia 2
JO - Giordania 2
ML - Mali 2
MT - Malta 2
NE - Niger 2
RE - Reunion 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BZ - Belize 1
CR - Costa Rica 1
GA - Gabon 1
GL - Groenlandia 1
HT - Haiti 1
LB - Libano 1
LT - Lituania 1
LU - Lussemburgo 1
Totale 20.559
Salva come PNG Salva come JPEG
Città #
Chandler 1.160
Beijing 911
Dublin 716
Houston 560
Fairfield 553
Ann Arbor 412
Ashburn 367
Jacksonville 351
Torino 336
Villeurbanne 336
Nyköping 293
Singapore 284
Dearborn 280
Wilmington 280
Princeton 264
Woodbridge 257
Medford 247
Redwood City 219
Seattle 215
Cambridge 200
Warsaw 192
Milan 159
Vienna 135
Pisa 134
Dong Ket 111
Frankfurt am Main 109
Boston 100
Ottawa 99
Boardman 85
Guangzhou 72
New York 57
Turin 55
Fremont 54
Toronto 53
Santa Clara 49
Shanghai 49
Verona 49
Brussels 46
London 42
Nanjing 41
Rome 41
Tokyo 35
Norwalk 34
Groslay 33
Madrid 33
Taipei 33
Hefei 31
San Diego 31
Los Angeles 29
Chengdu 28
Lachine 28
Düsseldorf 27
Hangzhou 26
Helsinki 24
Mountain View 23
Amsterdam 22
Seoul 22
Aarhus 20
Bologna 20
Chicago 20
Falls Church 20
Napoli 20
Wuhan 20
Detroit 18
Jinan 18
Würzburg 18
Kunming 17
Phoenix 17
Duncan 16
Edinburgh 16
Hong Kong 16
Munich 16
Saint Paul 16
São Paulo 16
Barcelona 15
Bricherasio 15
Istanbul 15
Kinshasa 15
Naples 15
Zhengzhou 15
Chongqing 14
Gent 14
Hamburg 14
Kiel 14
Nashville 14
Gainesville 13
Santiago 13
Shenyang 13
Silver Spring 13
Berlin 12
Brescia 12
Changsha 12
Des Moines 12
Minneapolis 12
Mumbai 12
Parma 12
Pune 12
Athens 11
Dallas 11
Florence 11
Totale 11.077
Salva come PNG Salva come JPEG
Nome #
Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients. 717
Impulse control behaviors and subthalamic deep brain stimulation in Parkinson disease 650
FRATTURA DEL CONDILO OCCIPITALE. OSSERVAZIONE DI UN CASO E REVISIONE DELLA LETTERATURA 571
Instrumented gait analysis for an objective pre/post assessment of tap test in normal pressure hydrocephalus. 522
Idiopathic delayed-onset edema surrounding deep brain stimulation leads: Insights from a case series and systematic literature review 517
Progressive gait ataxia following deep brain stimulation for essential tremor: adverse effect or lack of efficacy? 478
Nanoparticelle lipidiche solide per veicolare farmaci antitumorali oltre la barriera emato-encefalica, in particolare per il trattamento dei tumori cerebrali 477
TRAITEMENT ANTIBIOTIQUE PROPHYLACTIQUE DES COMPLICATIONS INFECTIEUSES POST-OPERATOIRES EN NEUROCHIRURGIE. 416
Transient effects of 80 Hz stimulation on gait in STN DBS treated PD patients: a 15 months follow-up study. 330
Solid Lipid Nanoparticles for Potential Doxorubicin Delivery in Glioblastoma Treatment: Preliminary In Vitro Studies. 323
Positive-charged solid lipid nanoparticles as paclitaxel drug delivery system in glioblastoma treatment 323
Subthalamic deep brain stimulation: clinical and neuropsychological outcomes in mild cognitive impaired parkinsonian patients. 322
Characterization of the thalamic-subthalamic circuit involved in the placebo response through single-neuron recording in Parkinson patients 288
Fluorescence and image guided resection in high grade glioma. 278
Medical therapy and subthalamic deep brain stimulation in advanced Parkinson's disease: a different long-term outcome? 259
80 Hz versus 130 Hz subthalamic nucleus deep brain stimulation: effects on involuntary movements. 256
Subthalamic nucleus deep brain stimulation outcome in young onset Parkinson's disease: a role for age at disease onset? 249
Deep Brain Stimulation of the subthalamic nucleus does not negatively affect social cognitive abilities of patients with Parkinson's disease 248
Vagus nerve stimulation for treatment-resistant mood disorders: a long-term naturalistic study 219
Pontine compression caused by "surgiceloma" after trigeminal decompression: case report and literature review 209
Does intraoperative microrecording really increase the risk of hemorrhagic complications in deep brain stimulation? 208
Central neuropathic itch as the presenting symptom of an intramedullary cavernous hemangioma: case report and review of literature. 198
When words are painful: unraveling the mechanisms of the nocebo effect 195
Alessitimia e depressione in pazienti con malattia di Parkinson sottoposti a deep brain stimulation del subtalamo: uno studio caso-controllo. 191
Surgical indication in Menière's disease therapy: clinical and epidemiological aspects. 178
Teaching neurons to respond to placebos 174
Stimulation of the subthalamic area modulating movement and behavior 168
UN CASO DI NEURINOMA ORIGINATO NEL SENO CAVERNOSO 142
La stimolazione del nervo vago (VNS) nel trattamento della depressione maggiore resistente: risultati preliminari di uno studio clinico sperimentale spontaneo 141
Analisi dei costi della stimolazione cerebrale profonda (DBS) nella malattia di Parkinson: uno studio osservazionale su pazienti italiani. 139
Impulsivities and Parkinson's disease: Delay aversion is not worsened by Deep Brain Stimulation of the Subthalamic Nucleus 139
Alexithymia in patients with Parkinson's disease treated with DBS of the subthalamic nucleus: a case-control study 135
Solid Lipid Nanoparticles Loaded with Antitumor Lipophilic Prodrugs Aimed to Glioblastoma Treatment: Preliminary Studies on Cultured Cells 132
Antigenic and genotypic similarity between primary glioblastomas and their derived neurospheres. 129
THE TREATMENT OF NEUROSURGICAL INFECTIONS BY LASERS AND PORPHYRINS. 128
Solid lipid nanoparticles by coacervation loaded with a methotrexate prodrug: preliminary study for glioma treatment 124
CRANIECTOMIA DECOMPRESSIVA POST-TRAUMATICA SEGUITA DA MIOSARCOMA IN SEDE DI INTASCAMENTO SOTTOCUTANEO DEL VOLET OSSEO. OSSERVAZIONE DI UN CASO 120
Neuropsychological changes 1-year after subthalamic DBS in PD patients: a prospective controlled study 118
Personality and Deep Brain Stimulation of the subthalamic nucleus in Parkinson's disease 114
Open versus hidden medical treatments: the patient's knowledge about a therapy affects the therapy outcome. 113
Molecular biology of gliomas: present and future challenges. 108
TP53 gene polymorphisms and mutations’ correlation in blood and tumoral tissue in a group of patients with gliomas 107
Electrophysiological properties of thalamic, subthalamic and nigral neurons during the anti-parkinsonian placebo response 106
Studio clinico sperimentale spontaneo sul trattamento della depressione maggiore resistente mediante stimolezione del nervo vago: risultati a due anni di follow-up 106
Are acute subdural hematomas possible without head trauma? 106
Comparison of Allogeneic and Syngeneic Rat Glioma Models by Using MRI and Histopathologic Evaluation 106
The dominant-subthalamic nucleus phenomenon in bilateral deep brain stimulation for Parkinson's disease: Evidence from a gait analysis study 104
ROLE OF NITRIC OXIDE IN GLIOBLASTOMA THERAPY: ANOTHER STEP TO RESOLVE THE TERRIBLE PUZZLE? 102
Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: Relationship between the electrode trajectory and cognitive decline 101
Methotrexate-Loaded Solid Lipid Nanoparticles: Protein Functionalization to Improve Brain Biodistribution 99
Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. 94
Experimental glioblastoma in Fisher rat model: treatment with a biocompatible system as carrier of methotrexate drug. 94
Uso sperimentale del laser e dell'ematoporfirina nelle infezioni: studio in vitro e in vivo. 92
Deep brain stimulation of subthalamic nucleus: behavioral modifications and familiar relations 91
The placebo effect on bradykinesia in Parkinson's disease with and without prior drug conditioning 91
Antiparkinsonian therapy modifications in PD patients after STN DBS: A retrospective observational analysis 89
Alcune indicazioni all'uso della colla biologica in Neurochirurgia. 88
ARGUMENTS IN FAVOUR OF AN EARLIER APPLICATION OF STN-DBS IN THE COURSE OF PARKINSON DISEASE. 88
Risk of Recurrence of Chronic Subdural Hematomas After Surgery: A Multicenter Observational Cohort Study 88
An original study of mastication in patients with advanced Parkinson disease with and without therapy and deep brain stimulation. 86
Solid lipid nanoparticles as antineoplastic drugs vehicles in glioblastoma multiforme: in vitro and in vivo pathological effects. 86
Deep brain stimulation in Parkinson's disease: comparison of pre- and post-operative neuropsychological evaluation 82
Acute traumatic central cord syndrome. 81
Deep brain stimulation of the subthalamic nucleus in PD: an analysis of the exclusion causes 80
Autonomic and emotional responses to open and hidden stimulations of the human subthalamic region 80
“ Effetti cognitivo comportamentali della dbs del subtalamo in pazienti parkinsoniani: follow-up a 5 anni” 80
Apatia in pazienti con malattia di Parkinson sottoposti a DBS del nucleo subtalamico. 80
3 years comparison between duodopa and Deep Brain Stimulation 80
Beyond Nine Years of Continuous Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s Disease 79
Advanced therapies in Parkinson's disease: Long-term retrospective study 79
Expectation modulates the response to subthalamic nucleus stimulation in Parkinsonian patients. 78
Does subthalamic stimulation induce personality modifications in Parkinson's disease? A Rorschach Test explorative study 78
Apathy and verbal fluency in STN-stimulated PD patients 78
Temporal changes in movement time during the switch of the stimulators in Parkinson's disease patients treated by subthalamic nucleus stimulation. 78
5-aminolevulinic acid and neuronavigation in high-grade glioma surgery: results of a combined approach. 78
Is Pseudotumor Cerebri An Unusual Expression of Chiari Syndrome? A Case Report and Review of the Literature 77
L’IMPIEGO DI SORGENTI LASER E DI SOSTANZE FOTOSENSIBILIZZANTI NELLA PATOLOGIA INFETTIVA NEUROCHIRURGICA. 75
Chronic deep brain stimulation of the subthalamic nucleus for Parkinson's disease: effects on cognition, mood, anxiety and personality traits 75
Tumors arising within the spinal canal. 75
Methotrexate loaded SLN obtained by coacervation for potential glioblastoma treatment 75
Apathy and verbal fluency in STN-stimulated PD patients: An observational follow-up study 74
“Apathy and verbal fluency in STN-stimulated PD patients”. 74
Comparison of bilateral subthalamic deep brain stimulation (STN-DBS) and duodenal levodopa infusion (DLI) in advanced Parkinson's disease (PD) patients 73
A survey of Italian cases of dystonia treated by deep brain stimulation. 73
Deep brain stimulation of the subthalamic nucleus: anatomical, neurophysiological and outcome correlations with the effects of stimulation 73
Can cardiosympathetic and cardiovagal indices predict the efficacy of vagal nerve stimulation in depression? A pilot study 72
Daytime sleepiness improvement following bilateral chronic electrical stimulation of the subthalamic nucleus in Parkinson's disease. 72
Effects of subthalamic stimulation on brain electrical activity during a motor task in Parkinson's disease 72
Atypical growth pattern of a meningioma in an adult 72
Atypical Gait Cycles in Parkinson’s Disease 72
TRATTAMENTO DELLE METASTASI CEREBRALI 71
HEMATOPORPHYRIN AND LASER FOR THE TREATMENT OF C.N.S. INFECTIONS. 71
SLN obtained by coacervation for potential anti-tumour drug delivery to the brain. 71
Hyperprolactinaemia and prolactine binding in benign intracranial tumours. 71
Asymptomatic deep venous thrombosis in advanced Parkinson's disease: Implications for DBS surgery 71
The dominant subthalamic nucleus: A gait analysis study 71
Comparison of subthalamic nucleus Deep Brain Stimulation and Duodopa in the treatment of advanced Parkinson's disease. 70
Can cardiosympathetic and cardiovagal indices predict the efficacy of vagal nerve stimulation in depression? A pilot study 70
Earlier versus later subthalamic deep brain stimulation in Parkinson's disease 70
Electroencephalographic responses to intraoperative subthalamic stimulation 69
Totale 15.590
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.626
article - articoli 0
book - libri 0
conference - conferenze 11.516
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.142
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.843 0 0 230 300 264 592 368 239 281 244 215 110
2020/20212.650 299 159 210 138 246 198 220 157 341 228 175 279
2021/20222.569 99 112 100 196 118 135 121 133 107 197 647 604
2022/20233.763 427 347 109 347 341 923 282 232 331 103 219 102
2023/20241.691 182 298 108 117 132 175 88 105 20 106 121 239
2024/2025489 134 299 56 0 0 0 0 0 0 0 0 0
Totale 21.380